June 19, 2013 6:32 AM ET

Pharmaceuticals

Company Overview of Vantia Ltd.

Company Overview

Vantia Ltd., a pharmaceutical company, engages in the development and commercialization of molecule drugs for medical markets. Its products are used for the treatment of nocturia, dysmenorrhoea, respiratory disorders, inflammation, oncological, and fibrotic diseases. The company was founded in 2007 and is based in Southampton, the United Kingdom.

Southampton Science Park

1 Venture Road

Chilworth

Southampton,  SO16 7NP

United Kingdom

Founded in 2007

Phone:

44 23 8076 3400

Fax:

44 23 8076 6755

www.vantiatherapeutics.com

Key Executives for Vantia Ltd.

Chief Executive Officer
Age: 37
Founder and Chief Operating Officer
Chief Financial Officer
Head of Development
Head of Regulatory Affairs
Compensation as of Fiscal Year 2012.

Similar Private Companies By Industry

Company Name Region
Convergence Pharmaceuticals Limited Europe
Simbec Research Ltd. Europe
Circassia Limited Europe
Co-Pharma Limited Europe
KBiosciences Limited Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 27, 2012
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vantia Ltd., please visit www.vantiatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.